AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

PI-YSP-0111 Formulation on Human Gut Microbiota and Body Composition

RecruitingNAAges 18 Years - 65 YearsAllTaipei Medical University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The expected outcome of this study is that continuous 8-week supplementation with the PI-YSP-0111 prebiotic formulation will exert beneficial effects on gut microbiota modulation and liver health.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Healthy males or females aged 18 to 65 years. 2. BMI between 23.0 and 40.0 kg/mยฒ. 3. Waist circumference: โ‰ฅ 90 cm for males and โ‰ฅ 80 cm for females. 4. Participants are willing to maintain their usual dietary habits, daily routines, and physical activity levels during the study period, and have no plans to relocate. 5. Participants have fully understood the study procedures and have signed the informed consent form. Exclusion Criteria: 1. Presence of gastrointestinal diseases, such as inflammatory bowel disease, irritable bowel syndrome, gastroesophageal reflux disease, Crohn's disease, or a history of bariatric surgery. 2. Recent history of acute gastroenteritis, constipation or diarrhea; psychiatric disorders (e.g., depression or schizophrenia); cardiovascular diseases (e.g., hypertension); known allergy or hypersensitivity to the investigational product; extreme dietary habits; significant body weight change (\>4.5 kg) within the past three months; recent use of antibiotics or antifungal agents; or use of medications affecting gastrointestinal function (such as probiotics, laxatives, or nonsteroidal anti-inflammatory drugs \[NSAIDs\]). 3. Exposure to unapproved medications, alcohol abuse, or substance abuse. 4. Female-specific conditions, including significant gastrointestinal symptoms during menstruation, irregular menstrual cycles, pregnancy, planned pregnancy, or breastfeeding (participants who become pregnant during the study period will also be excluded). 5. Short-term use of corticosteroids, nonsteroidal anti-inflammatory drugs, immunosuppressive agents, interferons, or immunomodulatory agents within the past one month. 6. Use of any weight-loss medications (including oral agents, injections, or traditional Chinese medicine) within the past three months. 7. Participation in any other interventional clinical study within the past one month. 8. History of cancer or current malignancy within the past two years, except for non-melanoma skin cancer. 9. Occurrence of major trauma or any surgical procedures within the past one month. 10. History of diabetic ketoacidosis.
๐Ÿ’Š

What it tests

  • PI-YSP-0111 formulation (High-dose)
  • PI-YSP-0111 formulation (Low-dose)
  • Placebo group(High-dose)
  • Placebo group(Low-dose)
๐Ÿ“

Where

2 sites
Taipei Medical University
Taipei, Taiwan
Taipei Municipal WanFang Hospital(Managed by Taipei Medical University)
Taipei, Taiwan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy